Search Results

Showing: 5252 Results

Trial

Simmons Cancer Institute

KO-MEN-008: Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia

Active recruiting

Examining the safety, tolerability, and effectiveness of investigational drug ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia. The study drug will be examined with the following agents: FLAG-IDA, low-dose cytarabine, and gilteritinib.

Profiles

Kody Bolk, MD

Assistant Professor

(ENT) Otolaryngology- Head and Neck Surgery

Profiles

Kortni Kemper

Kortni Kemper, MD

Internal Medicine

Profiles

Krishna Rao, MD

Associate Professor, Hematology/Oncology, Department of Internal Medicine

Internal Medicine

Profiles

Krishna Taneja

Krishna Taneja, MD

Psychiatry

Profiles

Krista Bonney

Krista Bonney, MD

General Surgery

General Results

Kristan Eaton

Executive Director of Human Resources

Human Resources

Profiles

Kristen Cecil

Kristen Cecil, MD

Obstetrics and Gynecology

Profiles

Kristen Leadbetter, MD

Assistant Professor of Clinical Pediatrics - Neonatology, Co-Director Undergraduate Medical Education Program

Profiles

Kristin Delfino, PhD

Research Associate Professor Center for Clinical Research | Department of Surgery

Center for Clinical Research (CCR)